- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07620691
N95 Masks for Lung Health While Golfing During Wildfire Season
May 26, 2026 updated by: Phil Chilibeck, University of Saskatchewan
A Pilot / Feasibility Study on Cardiorespiratory Health of Golfers During Wildfire Season
Lung health is negatively affected during wildfire season by increased smoke pollution.
Wearing N95 masks protects lung health in the short-term.
The purpose of our study is to assess whether wearing of N95 facemasks on days with moderate to high air pollution in people who go outside to golf on a regular basis (two or more times per week) for two months during the wildfire season projects lung health.
Study Overview
Detailed Description
Wildfire smoke negatively affects lung health.
Across North American, millions of people are exposed to wildfire smoke most summers.
The purpose of our study is to determine whether people who golf regularly (two or more times per week) can use N95 masks to protect their lungs from wildfire smoke.
Forty regular golfers will be randomized to receive N95 masks or not to receive masks.
All participants will be told to follow guidelines for outdoor activity based on Air Quality Health Index readings.
Those randomized to wear N95 facemasks will be asked to wear these on days they golf where Air Quality Health Index indicates moderate risk or higher.
The main outcome is compliance with wearing the N95 mask.
Secondary outcomes include changes in lung function, blood pressure, and respiratory symptoms over two months.
Study Type
Interventional
Enrollment (Estimated)
40
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Philip Chilibeck, PhD
- Phone Number: 3062303849
- Email: phil.chilibeck@usask.ca
Study Locations
-
-
SK - Saskatchewan
-
Saskatoon, SK - Saskatchewan, Canada, S7N 5B2
- Recruiting
- University of Saskatchewan
-
Contact:
- Philip Chilibeck, PhD
- Phone Number: 3062303849
- Email: phil.chilibeck@usask.ca
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Golf on a regular basis (two or more times per week)
Exclusion Criteria:
- Smoker
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: N95 mask
N95 masks will be worn outdoors when Air Quality Health Index indicates moderate risk or higher (4 or higher)
|
N95 mask to be worn outside when golfing when Air Quality Health Index reading indicates moderate risk or higher
|
|
No Intervention: No N95 mask
No N95 masks will be provided to participants
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in compliance with wearing of N95 masks (number of times divided by days with moderate or higher air pollution)
Time Frame: 8 weeks
|
compliance with wearing the N95 masks
|
8 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in forced expiratory volume in one second (L)
Time Frame: 8 weeks
|
Force expiratory volume in one second measured with spirometry
|
8 weeks
|
|
Change in forced vital capacity (mL)
Time Frame: 8 weeks
|
Forced vital capacity measured by spirometry
|
8 weeks
|
|
Change in forced expiratory flow at 25% to 75% of vital capacity (mL)
Time Frame: 8 weeks
|
forced expiratory flow at 25% to 75% of vital capacity measured by spirometry
|
8 weeks
|
|
Change in respiratory symptoms (score out of 12)
Time Frame: 8 weeks
|
Respiratory symptoms determined by the Dyspnoea-12 questionnaire
|
8 weeks
|
|
Change in systolic blood pressure (mmHg)
Time Frame: 8 weeks
|
Systolic blood pressure measured by an automatic sphygmomanometer
|
8 weeks
|
|
Change in diastolic blood pressure (mmHg)
Time Frame: 8 weeks
|
Diastolic blood pressure measured by an automatic sphygmomanometer
|
8 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Philip Chilibeck, PhD, University of Saskatchewan
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 26, 2026
Primary Completion (Estimated)
September 1, 2026
Study Completion (Estimated)
December 31, 2026
Study Registration Dates
First Submitted
May 26, 2026
First Submitted That Met QC Criteria
May 26, 2026
First Posted (Actual)
June 2, 2026
Study Record Updates
Last Update Posted (Actual)
June 2, 2026
Last Update Submitted That Met QC Criteria
May 26, 2026
Last Verified
May 1, 2026
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Immune System Diseases
- Respiratory Tract Diseases
- Lung Diseases
- Bronchial Diseases
- Lung Diseases, Obstructive
- Respiratory Hypersensitivity
- Hypersensitivity, Immediate
- Hypersensitivity
- Asthma
- Surgical Equipment
- Equipment and Supplies
- Manufactured Materials
- Technology, Industry, and Agriculture
- Protective Devices
- Personal Protective Equipment
- Surgical Attire
- Equipment and Supplies, Hospital
- Respiratory Protective Devices
- N95 Respirators
Other Study ID Numbers
- 6402
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Bronchial Asthma
-
Vanderbilt University Medical CenterWithdrawnAsthma in Children | Asthma Attack | Asthma Acute | Acute Asthma Exacerbation | Asthma; StatusUnited States
-
Johann Wolfgang Goethe University HospitalCompleted
-
AstraZenecaActive, not recruitingBronchial Asthma (Only the Patients With Severe or Intractable Bronchial Asthma Which Could Not be Controlled With the Existing Therapy)Japan
-
Academisch Medisch Centrum - Universiteit van Amsterdam...ZonMw: The Netherlands Organisation for Health Research and DevelopmentRecruitingSevere Asthma | Asthma Exacerbations | Bronchial ThermoplastyNetherlands
-
University of California, San FranciscoCompletedAsthma in Children | Asthma Attack | Asthma Acute | Asthma ChronicUnited States
-
SamA Pharmaceutical Co., LtdCompleted
-
Value Outcomes Ltd.AstraZenecaCompletedAsthma, Bronchial | Bronchial Asthma | Asthma Chronic | Asthma; EosinophilicCzechia
-
Astellas Pharma IncAstellas Pharma Europe B.V.CompletedAsthma, Bronchial | Bronchial AsthmaRussian Federation, Poland, Germany, Ukraine, Czech Republic
-
Astellas Pharma IncAstellas Pharma Europe B.V.CompletedAsthma, Bronchial | Bronchial AsthmaRussian Federation, Hungary, Germany, Poland, Bulgaria, Ukraine, Czech Republic
-
Parc de Salut MarActive, not recruitingAsthma in Children | Persistent Asthma | Asthma ExacerbationSpain
Clinical Trials on N95 mask
-
Brigham and Women's HospitalWithdrawnRespiratory Tract Infections | Respiratory Disease | Infection, CoronavirusUnited States
-
McMaster UniversityHealth CanadaCompleted
-
National University Health System, SingaporeCompleted
-
Riphah International UniversityCompletedHealthy VolunteersPakistan
-
Qilu Hospital of Shandong UniversityCompleted
-
McMaster UniversityUniversity of AlbertaCompletedCoronavirus | N95 | Medical MaskCanada, Egypt, Israel, Pakistan
-
Bozok UniversityCompletedCovid-19 | Pregnant | Mask | FetusTurkey
-
University of ArkansasCompleted
-
Mayo ClinicCompletedCovid19 | Tuberculosis | Respiratory Viral InfectionUnited States
-
Bartın UnıversityBartin State HospitalRecruitingDizziness | Headache | Heart Rate Determination | SpO2 | Eye Allergies | Muscle Aches | Muscle Weakness | Patient | Fatigue Symptom | Abdominal Pain (AP) | Surgical Smoke Exposure | Occupational Exposure to Surgical Smoke | Nause and Vomiting | DispneaTurkey (Türkiye)